BWX Technologies, Inc. (BWXT)
| Market Cap | 5.49B |
| Revenue (ttm) | 2.20B |
| Net Income (ttm) | 312.09M |
| Shares Out | 91.22M |
| EPS (ttm) | 3.38 |
| PE Ratio | 17.91 |
| Forward PE | 21.14 |
| Dividend | $0.88 (1.46%) |
| Ex-Dividend Date | Nov 18, 2022 |
| Volume | 131,612 |
| Open | 60.54 |
| Previous Close | 60.55 |
| Day's Range | 59.76 - 60.54 |
| 52-Week Range | 42.77 - 62.84 |
| Beta | 0.79 |
| Analysts | Buy |
| Price Target | 68.00 (+12.86%) |
| Earnings Date | Feb 23, 2023 |
About BWXT
BWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. It operates in three segments: Nuclear Operations Group, Nuclear Power Group, and Nuclear Services Group. The Nuclear Operations Group segment provides precision naval and critical nuclear components, reactors, nuclear fuel, and assemblies for the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program and other uses; missile launch tubes for United States Navy submarines; clo... [Read more]
Financial Performance
In 2021, BWXT's revenue was $2.12 billion, an increase of 0.03% compared to the previous year's $2.12 billion. Earnings were $305.87 million, an increase of 9.76%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for BWXT stock is "Buy." The 12-month stock price forecast is $68.0, which is an increase of 12.86% from the latest price.
News
BWXT Medical and Laurentis Complete Key Tc-99m Generator Program Milestone
OTTAWA, Ontario--(BUSINESS WIRE)--Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation's (OPG) Darlington Nuclear Generating Station, thanks to the installation...
BWX Technologies to Announce Fourth Quarter and Full-Year 2022 Results on Thursday, February 23
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing fourth quarter and full-year 2022 results on Thursday, February 23, 2023, after marke...
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
- Agreement augments Fusion's existing isotope supply as pipeline of clinical stage actinium-based radiopharmaceuticals grows - Furthers BWXT Medical's position as a global leader in medical isotope...
BWXT Promotes Chip Whitford to Senior Vice President and General Counsel
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) has promoted Ronald O. (Chip) Whitford, Jr. to the position of senior vice president, general counsel, chief compliance officer a...
The 7 Hottest Defense Stocks to Own for 2023 and Beyond
A year ago, the outlook was unclear for some of the hottest defense stocks. The U.S. had just pulled its troops out of Afghanistan, and analysts were pointing to a potential period of isolationism.
BWXT Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) today with officials from the U.S. Department of Defense, Department of Energy, NASA and Idaho National Laboratory celebrated the...
BWX Technologies (BWXT) Q3 Earnings and Revenues Lag Estimates
BWX (BWXT) delivered earnings and revenue surprises of -4.17% and 0.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
KYOCY vs. BWXT: Which Stock Is the Better Value Option?
KYOCY vs. BWXT: Which Stock Is the Better Value Option?
Should You Buy BWX Technologies Stock At Around $55?
BWX Technologies stock (NYSE: BWXT), a supplier of nuclear components and fuel, has seen a 9% rise this year, significantly outperforming the broader S&P500 index, down 23%.
KYOCY vs. BWXT: Which Stock Should Value Investors Buy Now?
KYOCY vs. BWXT: Which Stock Is the Better Value Option?
BWX Technologies to Announce Third Quarter 2022 Results on Monday, November 7
LYNCHBURG, Va.
TEL vs. BWXT: Which Stock Is the Better Value Option?
TEL vs. BWXT: Which Stock Is the Better Value Option?
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
OTTAWA, Ontario--(BUSINESS WIRE)---- $BWXT--BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
BWXT Names Robert Duffy as Chief Administrative Officer
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT--BWXT Names Robert Duffy as Chief Administrative Officer
BWX Technologies (BWXT) Q2 Earnings and Revenues Surpass Estimates
BWX (BWXT) delivered earnings and revenue surprises of 12.33% and 3.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
BWX Technologies Reports Robust Second Quarter 2022 Results; Increases 2022 Revenue and Adjusted EBITDA(1) Guidance
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT #earnings--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2022 revenue of $554 million, a 10% increase comp...
BWX Technologies (BWXT) Earnings Expected to Grow: Should You Buy?
BWX (BWXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BWXT Names Sharon H. Smoot as President of Nuclear Operations Group
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT--BWXT Names Sharon H. Smoot as President of Nuclear Operations Group
BWX Technologies to Announce Second Quarter 2022 Results on Monday, August 8
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT #earnings--BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing second quarter 2022 results on Monday, August 8, 2022, after market...
BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power
CAMBRIDGE, Ontario--(BUSINESS WIRE)---- $BWXT--BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power
BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
OTTAWA, Ontario--(BUSINESS WIRE)---- $BWXT--BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products